Summary. After intravenous and oral administration of radioactive aldosterone to normal subjects, 7.3 + 0.4 (SE) and 5.4 ± 0.5 (SE) %, respectively, of the dose was recovered from a 48-hour collection of urine as aldosterone released by mild acid hydrolysis (from aldosterone 18-glucuronide), and 35 + 5 (SE) and 39 + 4 (SE) %, respectively, was recovered as tetrahydroaldosterone after incubation with 1e3-glucuronidase.
Introduction
A batch of radioactive material obtained from a commercial source as aldosterone-4-14C has been tive compound in the material had approximately the same running properties as aldosterone on both Kieselguhr column and paper chromatography using the Bush B5 solvent system (1). Only one major peak containing 14C was found with either chromatographic method. No other peak in the column eluates had more than 2.5% of the total radioactivity. The radioactive compound in the pooled fractions of the major peak was administered orally with an intravenous injection of aldosterone-7-3H to normal subjects. This was part of a study on the metabolism of aldosterone using an approach similar in principle to that employed by Bledsoe and co-workers (2) .
It was found that the pattern of excretion of radioactivity in the various urinary metabolites after administration of the 14C compound was markedly different from that previously found after oral administration of authentic aldosterone-4-14C although the metabolism of aldosterone-7-sH given intravenously to the same subjects was not unusual.
Subsequent investigation showed that the material supplied was over 90% 17-isoaldosterone-4-14C and contained only about 2%o aldosterone-4-14C. The running speed of 17-isoaldosterone is slightly but definitely slower than that of aldosterone on column chromatography using the Bush B5 solvent system. Because of this difference in the properties of the two compounds on column chromatography, the initial purification had eliminated the trace of aldosterone-4-14C originally present, and the administered material was pure 17-isoaldosterone-4-14C. We have previously observed radioactivity with the properties of 17-isoaldosterone in preparations of radioactive aldosterone, particularly after prolonged storage (3). Schmidlin and co-workers (4) described its formation after hydrolysis of aldosterone 21-monoacetate with strongly alkaline solutions or after similar treatment of other aldosterone derivatives (4) . However, in such impure preparations the 17-isoaldosterone is usually seen as a minor secondary peak close to but clearly separable from the primary peak of aldosterone in the Bush B5 column eluates. The predominance of 17-isoaldosterone in the material supplied actually prevented its imsiduronic acid aldosterone 'y-lactone: 18-hydroxy-ll,8: 18-oxidoandrost-4-en-3-one-17,9-carboxylic acid (18: 20-lactone); 17-isoaldosterone etioacid = 11,B,21-dihydroxy-18-oxo-androst4-ene-17a-carboxylic acid.
mediate recognition by preliminary investigation, as the peak positions of a particular compound tend to vary slightly on different columns and, in order to obtain high specific activity material, we considered it undesirable to add carrier aldosterone as a marker for the purification.
Orally administered 17-isoaldosterone-4-14C was excreted almost quantitatively as an acid-labile conjugate and to a negligible extent as metabolites released from the urine by incubation with /8-glucuronidase. This is of interest because of the comparison with the metabolism of aldosterone, where the excretory pattern is almost reversed, and in view of the known difference in structure of the two 17-isomers.
Methods
All the radioactive compounds administered 2 were finally purified on a 60-cm column 1 cm in diameter with 28 g Celite and 14 ml methanol-water (1: 1 vol: vol) as the stationary phase. Benzene was the mobile phase. Details of the column and the source and purification of the solvents have previously been published (5) . Fiveml fractions were collected, and, in all cases, the two fractions containing the major peak of radioactivity were pooled and the other eluted material was discarded.
After purification of aldosterone-7-8H and aldosterone- Under similar conditions, aldosterone-4-14C was mainly converted to the 'y-lactone (8) , and 87% of the original radioactivity was extracted into the methylene dichloride. After neutralization of the alkaline solution containing the oxidation product of 17-isoaldosterone-4-10C [presumably 17-isoaldosterone etioacid (7)], 89% of the original radioactivity was extracted with methylene dichloride. This radioactive compound had a running speed of Rf 0.04 (Rcortleosteroee ettoacid = 0.11, and Raldonterone y-lactone = 0.08) in the paper system 75% glacial acetic acid/H20, cyclohexane/benzene 2:1 (9), and the resultant single radioactive peak found on scanning coincided with the soda fluorescence of the product from the authentic 17-isoaldosterone carrier. The product from about 3 gg of 17-isoaldosterone-4j'C put through the same procedure without carrier gave ultraviolet absorption (X = 254 mp) and positive soda fluorescence that coincided with the radioactive peak, but only a slow and weak tetrazolium reaction. About 90% of the radioactivity (2%o of the total) that remained in the methylene dichloride after the alkaline partition of the oxidation product of 17-isoaldosterone ran slower than aldosterone 'y-lactone in the Bush B3 system but together with 17-isoaldosterone etioacid in the acid paper system. Only 0.2%o of the total ran with aldosterone y-lactone.
The counts per minute due to 'H and 14C in a mixture of the aldosterone4-C and the aldosterone-7-'H were measured before and after conversion to the diacetate and purification of the derivative by column chromatography. There was no significant difference in the measured ratios of 'H to 14C in the pooled fractions.
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We concluded, therefore, that aldosterone-4-14C, aldosterone-7-'H, and 17-isoaldosterone-4-14C prepared after column chromatography were of satisfactory radiochemical purity for administration to the normal human subjects.
The 17-isoaldosterone-4-14C (0.86 Ac, 6 .1 ,ug) or aldosterone-4-C (0.86 uc, 6.1 /Ag) was made up in a 10% ethanolic solution of water for oral administration. This dose was swallowed and then immediately washed down with 6 ml water. The aldosterone-7-'H (4 ac, 0.044 Jzg) was administered intravenously in 10 ml 6% ethanolic solution of physiological saline. 17-Isoaldosterone-4-4C was given in the same solution as the aldosterone-7-'H when injected intravenously. The radioactive steroids were given to normal male and female volunteers, ranging in age from 25 to 40 years, who gave their informed verbal consents to the procedure and were on ad libitum electrolyte intakes. In all experiments, the aldosterone-7-H was given intravenously. Simultaneously, 17-isoaldosterone-4-"C or aldosterone-4.4G was given orally, or 17-isoaldosterone-4-"C was given in the same intravenous solution (Table I) .
Usually, urine was collected for 48 hours after administration of the radioactive compounds. A 1-L sample was extracted without pH adjustment with methylene dichloride (neutral extract), hydrolyzed by standing at room temperature (23°C) at pH 1 for 16 hours, and again extracted with methylene dichloride (acid extract) (5). Another 166-ml portion was hydrolyzed with #-glucuronidase and then extracted with ethyl acetate (enzyme glucuronide extract) (5) . A portion of these total extracts was assayed for radioactivity with corrections for quenching by the internal standard method for both isotopes (5) .
The residual neutral extract was acetylated after addition of carrier aldosterone and run on a partition column suitable for the purification of aldosterone diacetate (5). 17-Isoaldosterone diacetate ran faster than aldosterone diacetate in this system (RMado.t.rene diasetate = 1.8). The remaining acid fraction without added carrier underwent column chromatography without acetylation on a system suitable for the purification of aldosterone. 17-Isoaldosterone was eluted later than aldosterone in this system (R,0t..00.n.= 0.8). The enzymic glucuronide extract was chromatographed on a column suitable for the purification of tetrahydroaldosterone (5) . The characteristics of tetrahydro-17-isoaldosterone are unknown in this system, but it might be expected that the effective partition coefficient would be of the same order of magnitude as that of tetrahydroaldosterone. Fractions were examined with up to twice the retention volume of tetrahydroaldosterone. 17-Isoaldosterone had Rtetrahydroaxdosterone =2.0 on this column system, and aldosterone had Rtetr.jydroadosterone=2.5. Samples of the column fractions were assayed for both SC and 'H, and the nonisotopic compounds were located by paper chromatography and soda fluorescence or blue tetrazolium reaction. The per cent radioactivity as aldosterone and 17-isoaldosterone in the neutral and acid extracts and these compounds plus tetrahydroaldosterone or similar compounds, such as tetrahydro-17-isoaldosterone, in the enzymic glucuronide extract was estimated.
In one experiment, a 1-L sample from a 48-hour collection after intravenous injection of aldosterone-7-5H and oral administration of 17-isoaldosterone-4-"C was hydrolyzed at pH 1 and at room temperature for 0 to 15 and 15 to 30 hours, and the extracts in the two time intervals were analyzed for the radioactive steroids (Table II). In two experiments, after intravenous administration of both aldosterone-7-5H and 17-isoaldosterone-4-'C, portions from 0-to 6-, 6-to 12-, and 0-to 48-hour samples of urine were analyzed for aldosterone in the acid extract (Table II) . In two experiments, 17-isoaldosterone-4-14C was added to some normal nonradioactive urine after extraction at neutral pH and carried through the column chromatography of the acid extract, and its over-all recovery was estimated.
In an experiment in which two subjects had been injected intravenously with 17-isoaldosterone-4-j4C, samples of their pooled fractions that contained 17-isoaldos- hours; therefore, the specific activity and urinary production rate of the 17-isoaldosterone could be calculated. The production rate was corrected for the micrograms injected.
In all experiments, "C and 'H counts per minute were estimated by liquid scintillation counting with channel discrimination as previously described (5) . The vials were usually counted for 40 minutes. The counts per minute was usually high enough so that better than 5% statistical accuracy was achieved, except as discussed below. The 'C counts per minute as tetrahydroaldosterone or tetrahydro-17-isoaldosterone after administration of l 7-isoaldosterone-4-"C was negligible, and a maximal yield of 0.5% was calculated from the usual recovery and counting efficiency. The "C counts per minute as aldosterone (peak fraction of aldosterone diacetate from the column) in the neutral extract was low, being on the average about 4 (3H in the peak fraction averaged 200 cpm). The statistical accuracy of the ratio (K7) of "C to 'H for aldosterone in the neutral extract was therefore about 25%. The splanchnic extraction (H) can be calculated as (1 -Kir) 100% (2) . For normal subjects with greater than 90% extraction, the standard error in the estimation of H is therefore maximally 3%o. For subjects with lower extractions, the "C counts per minute as aldosterone was higher, and the calculated per cent error in the estimation of H was about the same as for normal subjects.
Results
After intravenous injection of aldosterone-7-3H, the mean per cent 3H radioactive dose found as aldosterone (isolated as the diacetate after acetylation from the neutral extract) was 0.21 + 0.02 (SE) %; as aldosterone from the acid extract, 7.3 ± 0.4 (SE) %; and as tetrahydroaldosterone from the enzymatic glucuronide extract, 33 ± 2 (SE) % (18 subjects) (Table I) . These values were not significantly different in the three groups of subjects, i.e., those simultaneously given an oral dose of aldosterone-4-14C or 17-isoaldosterone-4-14C or an intravenous dose of 17-isoaldosterone-4-14C (Table I) . They were also similar to those reported for normal subjects in other studies (2, 5, 10, 11) if appropriate corrections are made for recoveries. The recovery of aldosterone added to the urine after the neutral extraction and then isolated from the acid extract under the conditions used for our studies is about 70% (12) . The aldosterone released from the acid-labile conjugate by a 16-hour hydrolysis at pH 1, corrected for losses in the isolation of the released aldosterone but not for inefficiency of hydrolysis, was therefore about 10%o of the injected intravenous dose.
After oral administration of aldosterone-4-14C, the amount recovered from the urine as tetrahydroaldosterone after hydrolysis with f8-glucuronidase (39 + 4%7) is similar to that found after intravenous administration of aldosterone-7-3H (35 ± 5%o) (Table I) . However, the per cent of the oral dose recovered as aldosterone in the neutral extract (0.017 + 0.003%o) is greatly reduced (by a factor of about 12) compared to that found after intravenous administration (0.21 ± 0.04%o); the per cent of the oral dose released by acid hydrolysis as aldosterone was 5.4 ± 0.5%o, which is also significantly lower (p = 0.05) than the corresponding value after intravenous administration (7.2 + 0.6), but by a factor of only 1.3. After correction for losses, 7.7% of the oral dose of aldosterone-4-14C was calculated to have been released by acid hydrolysis.
After oral administration of 17-isoaldosterone-4-14C to the same group of normal subjects, 53 + 4%o of the dose was recovered as 17-isoaldosterone from the acid extract (Table I) . Of the 17-isoaldosterone-4-14C added to the urine after the neutral extraction, 63 and 67%o (mean 65) was recovered in the appropriate column fractions after chromatography of the acid extract. Therefore, after correction for losses, 82%o of the oral dose was found as 17-isoaldosterone after acid hydrolysis of the urine. Negligible radioactivity appeared in the position of aldosterone in the column fractions. After acetylation of a sample of the mea-sured eluted fractions, the radioactivity ran with 17-isoaldosterone diacetate on the Bush B3 paper system (run for 3j hours). The total acid extract contained from 45 to 89%. (mean 69) of the dose. Little radioactivity (< 5% total) was found in the fractions from the column after chromatography of the enzymic glucuronide extract after oral administration of 17-isoaldosterone-4-14C, and less than 0.5% was found in positions equivalent to or eluted more slowly than tetrahydroaldosterone ( Table I) . A sample of the total enzyme glucuronide extract also showed little, radioactivity (1.8 to 3.7%o, mean 2.8). These results showed that only very small amounts, if any, of the administered 17-isoaldosterone were excreted as tetrahydroaldosterone or the corresponding 17-tetrahydroisoaldosterone glucuronide.
After oral administration of 17-isoaldosterone-4-14C, only small amounts of radioactivity as the original compound were found in the neutral extract (0.03 to 0.81%, mean 0.32 ± 0.18) ; however, these values are considerably higher than those obtained as aldosterone in the neutral extract after oral administration of aldosterone-4-14C (0.017 ± 0.003%). The radioactivity was in the position of 17-isoaldosterone diacetate after chromatography of the acetylated extract. The 14C in the total neutral extract was also small (< 1 % for all samples).
After intravenous injection of 17-isoaldosterone-4-.14C, 0.20 ± 0.02% of the dose was 17-isoaldosterone in the neutral extract; this is similar to the amount found after oral administration of the same steroid (0.38 ± 0.18%) or the amount found as aldosterone in the neutral extract after intravenous injection of aldosterone (0.21 ± 0.02%). Less than 0.5% was detected as tetrahydroaldosterone or "17-isotetrahydroaldosterone" in the enzymic glucuronide extract after intravenous 17-isoaldosterone. The radioactivity in the corresponding total extracts was also low in the neutral (< 1 %) and enzymatic glucuronide extracts (< 5%, mean 3.8%o).
After intravenous injection of 17-isoaldosterone-4-14C, the radioactivity as 17-isoaldosterone in the acid extract was high [35 ± 3 (SE) %o] compared to that of aldosterone in the same extract after administration of aldosterone, but it was significantly (p = 0.01) lower than after oral 17-isoaldosterone (53 ± 4%o).
The metabolism of a particular steroid was similar for both women and men (Table I) .
Only a small amount of the dose was found as 17-isoaldosterone on column chromatography of the enzymatic glucuronide extract after oral administration of 17-isoaldosterone4-"'C, compared to the amount released by acid hydrolysis from the same urine (4.1 + 0.05%, 6 values). This indicates that the acid-labile metabolite of 17-isoaldosterone is not appreciably hydrolyzed by f8-glucuronidase (< 6%) for all six urines under conditions that quantitatively split other glucuronides (13) and partially hydrolyzed (22 ± 2%, 6 values) the corresponding metabolite of aldosterone (i.e., aldosterone 18-glucuronide) under the same conditions (13) .
Acid hydrolysis of one urine under the usual conditions for 16 hours gave 36% of an oral dose of 17-isoaldosterone-4-14C as 17-isoaldosterone. A second hydrolysis for another 16 hours gave only 2.6%o of the dose as the same compound (Table I). The corresponding values for the aldosterone from the acid extract as per cent of the aldosterone-3H injected were 6.8 and 0.96%o. This indicates that both the acid-labile conjugate of 17-isoaldosterone and aldosterone are rapidly hydrolyzed by the mild pH 1 and room temperature conditions for 16 hours.
After intravenous administration of both 17-isoaldosterone-4-14C and aldosterone-7-3H, the radioactivity as the appropriate acid-hydrolyzable conjugate was excreted nearly completely in 6 hours (Table II) . In two urines, aldosterone-3H and 17-isoaldosterone-14C in the acid extract of 0-to 6-, 6-to 12-, and 0-to 48-hour samples were measured, and the radioactivity in the 6-to 12-hour samples was a relatively minor amount (Table II) .
In two subjects, the urinary production rates of 17-isoaldosterone were found to be less than 5 ,ug per day.
Theory. If 69a fractional rate of transfer of steroid from the extrasplanchnic to the splanchnic pool; Ob fractional rate of transfer of steroid from the splanchnic to the extrasplanchnic pool;
Od and , == fractional rates of total irreversible metabolism of steroid in the splanchnic and extrasplanchnic pools, respectively; 0,e8 and 0_E _ fractional rates of metabolism of steroid to the particular metabolite in splanchnic and extrasplanch-nic pools, respectively; Gc' and Od' fractional rates of metabolism of steroid to compounds other than the particular metabolite in splanchnic and extrasplanchnic pools, respectively; ES and Ss total radioactivity (as a fraction of the injected radioactivity) in extrasplanchnic and splanchnic pools, respectively, after an oral dose; EE and SE total radioactivity (as a fraction of the injected radioactivity) in extrasplanchnic and splanchnic pools, respectively, after an intravenous dose; and a," and ae, = fractional rates of metabolism of radioactivity infused into splanchnic and extrasplanchnic pools to particular metabolite (rate of formation exclusively in the infused pool), then ae. = S heO and a. = EEIeE.
Then, K = fraction of oral dose in particular metabolite/fraction of intravenous dose in particular metabolite = K -GbGE + (Ga + Gc)Ga" GIaae + (Gb + Gd)GE = GbOeE + (Oa + Gc')GE11 + GSOG E (Gb + Gd,)GEE + Gae'S + GESG EmE1 [8] [ 9] assuming no formation of tetrahydroaldosterone in the extrasplanchnic pool.
Therefore, K can be calculated if KA and KT are known and it is assumed that the splanchnic extraction is 100% and tetrahydroaldosterone is formed exclusively in the splanchnic circulation.
If oral absorption of the steroid is incomplete, then the numerators in Equations 1 to 7 will be reduced correspondingly. The estimate of splanchnic extraction or the proportion of extrasplanchnic to splanchnic metabolism from the ratio of isotopes in the urinary free aldosterone or tetrahydroaldosterone will also be correspondingly too low. However, the estimate of the total proportion of the 18-glucuronide formed in the splanchnic circulation from the secreted hormone ( Equation 9) is not dependent on the amount of oral absorption, as KA and KT will be affected equally.
Discussion
After oral administration of 17-isoaldosterone to normal human subjects, about 80% (corrected for recovery but not for efficiency of hydrolysis) is recovered as an acid-labile conjugate from a 48-hour urine collection. Only small amounts (< 1 %) are found in the neutral extract or as metabolites released by incubation with 8-glucuronidase (< 4%). These metabolites would include 17-isoaldosterone itself, tetrahydro-17-isoaldosterone, or tetrahydroaldosterone. In contrast, after both oral and intravenous administration of aldosterone, about 35 %o is recovered as tetrahydroaldosterone after incubation of the urine with 8-glucuronidase. Also, after oral administration of the natural hormone, only 8%o is released by mild acid hydrolysis as aldosterone (corrected for recovery of the released aldosterone), and after intravenous injection, the corresponding quantity is 10% (2, 5, 10) . The difference in excretion of aldosterone in the acid extract after oral compared to intravenous injection of aldosterone has been postulated as being due to high hepatic extraction of aldosterone with some extrahepatic conversion of the intravenous aldosterone to the acid-labile conjugate (2, 14) .
Because of the rather unique and similar properties of the acid-labile conjugates of aldosterone and 17-isoaldosterone, particularly their ease of hydrolysis at pH 1 and room temperature, their resistance to hydrolysis with f8-glucuronidase, and their rapid renal excretion, considered together with the equivalence of the structure of the two steroids, except for the configuration of the 20-21 carbon side chain, it seems highly likely that both conjugates are similar in nature and therefore have a glucuronide residue at position 18 (13, 15) . It could be postulated that the preferential excretion of this type of conjugate in the metabolism of 17-isoaldosterone given either intravenously or orally is due to its increased rate of formation because of decreased hindrance by the side chain in the 17-iso position. On the other hand, the negligible excretion as tetrahydro-17-isoaldosterone or other metabolites released by ,8-glucuronidase could be due to specificity of the A-ring-reducing enzyme. It is presumably not due to specificity in the mechanism for conjugating after reduction of the ketone at position 3 in the A-ring, as the amount of radioactivity in the total neutral extract is also small. The increase in the excretion of the acidlabile conjugate could be due to lowered competition from the route of metabolism involving A-ring reduction. Similarly, the negligible excretion of the tetrahydro-17-isoaldosterone glucuronide could be due to specificity of the A-ringreducing mechanism or to increased competition from the 18-glucuronide route.
However, the negligible formation of the tetrahydro derivative does suggest some primary specificity in reduction of the A-ring. It would then be expected that the decreased rate of metabolism of the orally administered 17-isoaldosterone in the liver, due to lack of reduction of the A-ring, would lead to lowered hepatic extraction. Some of the orally administered steroid would then reach the kidney, which can form the acid-labile conjugate ( 14) . The proportion of 17-isoaldosterone metabolized to the conjugate would then be expected to be much higher than that of oral aldosterone. Since tritium-labeled 17-isoaldosterone is not yet available, it has not been possible to compare directly in the same subjects the amounts of radioactivity as 17-isoaldosterone in the neutral urinary extract after simultaneous oral and intravenous administration of the labeled steroid, but the similarity in the values found [0.32 + 0.18 (SE) %7o oral, and 0.20 ± 0.02 (SE) % intravenous] lends support to the hypothesis. This assumes that a negligible proportion of the 17-isoaldosterone in the neutral extract arises from hydrolysis of the conjugate in the body or urine, as seems to be the case with aldosterone (16) . In contrast, the 14C to MH ratio (KF) of aldosterone from the neutral extract (as the total column fractions) after 14C-labeled oral and MH-labeled intravenous aldosterone is 8 ± 1 (SE) %, giving a calculated splanchnic extraction for aldosterone of (1 -KF) 100% = 92 ± 1 (SE) % for normal subjects (Equation 4 ).
It would be expected, if this hypothesis concerning the metabolism of 17-isoaldosterone were correct, that the proportion of 17-isoaldosterone excreted as the acid-labile conjugate would not be markedly lower after oral than after intravenous administration, unlike the corresponding situation for aldosterone. This was found to be so. However, unexpectedly, the per cent of the dose excreted as the acid-labile conjugate was significantly higher after oral than after intravenous administration of 17-isoaldosterone-4-_4C. The mean values were significantly different (53 ± 4 and 35 ± 3%, respectively). Also, two subjects (D.P. and A.G., Table I ) were given both oral and intravenous 17-isoaldosterone-4-14C on separate occasions, and the per cent of the dose excreted as the 17-isoaldosterone 18-glucuronide was greater (140 and 144%, respectively) after the oral than after the intravenous administration.
One explanation of this, from Equation 6 , is that there is considerable extrasplanchnic metabolism of 17-isoaldosterone to compounds other than the acid-labile conjugate or metabolites released from urine by incubation with /8-glucuronidase or unconjugated metabolites. Some of the radioactivity in the urine after intravenous injection cannot be accounted for in terms of these known metabolites. Another, perhaps more likely, explanation is that orally administered 17-isoaldosterone is converted to the acid-labile conjugate before reaching the liver, i.e., in the intestinal lumen, which can form glucuronides of other steroids (17) .
The ratio (KA) of aldosterone in the acid extract after oral and intravenous administration of labeled aldosterone was 75 ± 4 (SE) % (nine subjects). This is significantly higher than the ratio found by Bledsoe and co-workers (2), 58 + 2 (SE) % (seven subjects), who simultaneously administered nonisotopic aldosterone by one route (orally in three and intravenously in four subjects) and aldosterone-3H by the other. We have no explanation for this discrepancy. Cheville and co-workers (14) , from analysis of renal venous blood and urinary excretion of conjugate in control subjects and patients with early heart failure, concluded that 61% (with confidence limits ± 20%o) of the acid-labile conjugate is formed in the kidney. From the isotopic ratios obtained in the present studies for aldosterone from the 18-glucuronide (0.75 ± 0.04) and tetrahydroaldosterone (1.14 ± 0.04), the proportion of the total 18-glucuronide formed in the splanchnic circulation produced from secreted hormone can be calculated (Equation 9) as 0.66 + 0.05 or 34 ± 5% of the total conjugate is formed from secreted hormone extrasplanchnically. This value is probably sig.-nificantly lower than the corresponding estimate of Cheville and associates (14) (61 ± 20% formed extrasplanchnically).
A possible reason for the discrepancies in the conclusions reached by using the two approaches could be similar to that proposed to explain the higher proportion of acid-labile conjugate of 17-isoaldosterone excreted after oral than after intravenous administration, i.e., formation of the acid-labile conjugate of aldosterone in the extrahepatic splanchnic tract.
The effect of this possibility on the validity of the method for obtaining splanchnic extractions of aldosterone without hepatic catheterization by simultaneous oral and intravenous injection of labeled aldosterone (18) must be considered. From the data presented here and those of Cheville and co-workers (14) , a maximum of one-half of the aldosterone 18-glucuronide formed after oral administration of aldosterone could be made in extrahepatic splanchnic tissues. However, only an over-all maximum of 20% of aldosterone is converted to this conjugate (13, 14) , and, therefore, this route of metabolism of oral aldosterone could account at the most for 10% of the over-all metabolism of aldosterone. Thus, this metabolism of orally administered aldosterone before it reached the liver would lower the 14C to 3H ratio (KF) as free aldosterone by a maximum of 10%o. The hepatic extraction is calculated as 1 -14C/3H, and the 14C to 3H ratio in normal subjects is usually < 0.1 and in subjects with abnormal metabolism, maximally 0.5. The error in the calculation of hepatic extractions would, therefore, be negligible, (< 1%) in normal subjects and less than 10% in patients with cirrhosis. Nevertheless, conclusions reached from the 14C to 3H ratio (KA) of aldosterone released from the aldosterone 18-glucuronide in the urine of a particular group of subjects could be significantly affected by abnormal conversion of aldosterone to the conjugate in the extrahepatic splanchnic tissues.
The increased formation of 18-glucuronide after intravenous injection of 17-isoaldosterone compared with aldosterone, as was discussed previously for the orally administered isomer, could be due to the lowered clearance of 17-isoaldosterone by the liver and the consequent increased relative formation of the conjugate by the kidney. However, after intravenous injection, the hepatic and renal circulations are in parallel for metabo-lism of the steroid, whereas after oral administration they are in series, and the hepatic extraction of aldosterone, but not of 17-isoaldosterone, is complete. The relative increase in acid-labile conjugate formation for 17-isoaldosterone compared with aldosterone would be expected to be greater when they are both given by the oral rather than the intravenous route. 5 The relative conversion of 17-isoaldosterone and aldosterone to their respective acid-labile conjugates was ten to one when both were given orally and five to one when they were given intravenously.
An analogous explanation has been given by Bledsoe and co-workers (2) feature of structure, such as the acetal at 11,18. The acid lability may be due to a similar structural feature.
The 17-isomer of aldosterone is converted to its corresponding acid-labile conjugate to a fivefold greater extent than aldosterone when both are given intravenously. Thus, if the isomers are not separated on chromatography of the acid extract, a 5% contamination of the aldosterone injected with its isomer could result in a 25%o error in a determination of the secretion rate of aldosterone. Paper chromatography of the aldosterone as the free compound on the Bush B5 system would usually not separate the isomers completely. Column chromatography with the Bush B5 system and paper or column chromatography of the diacetate in the Bush B3 system would be expected to be successful in this regard. If the tetrahydroaldosterone is used as the urinary metabolite for the secretion rate estimation, any per cent of contamination of the injected aldosterone with its 17-isomer would lead to the same per cent of error in the determination of secretion rate, as would also be the case if the acid-labile conjugate were used and the isomers separated. The problem would not then be so serious, as the effect would not be magnified.
The negligible radioactivity as aldosterone or tetrahydroaldosterone in the urinary extracts after administration of 17-isoaldosterone indicates that it is not appreciably converted to aldosterone in vivo. Some tritium as 17-isoaldosterone could be detected in the acid extract after intravenous injection of aldosterone-3H. This was at most 10% of the radioactivity as aldosterone in the same extract. Since the 17-isoaldosterone converted from aldosterone will be preferentially excreted as this type of conjugate, this result indicates very small (< 2%) conversion of aldosterone to 17-isoaldosterone.
The secretion rate of 17-isoaldosterone was also found to be negligible in two subjects, so it is unlikely that significant amounts of aldosterone originate from this compound in vivo.
It may be that 17-isomers of other steroids with the 4A 3 ketonic structure are also not metabolized by reduction of the A-ring in vivo. If this is so, investigation of their metabolism ma'y be useful in revealing other routes and sites of catabolism of the natural hormones.
